Literature DB >> 25182564

Synthesis and evaluation of arylpiperazines derivatives of 3,5-dioxo-(2H,4H)-1,2,4-triazine as 5-HT1AR ligands.

J S Dileep Kumar1, Vattoly J Majo2, Jaya Prabhakaran3, J John Mann4.   

Abstract

5-HT1AR agonist or partial agonists are established drug candidates for psychiatric and neurological disorders. We have reported the synthesis and evaluation of a series of high affinity 5-HT1AR partial agonist PET imaging agents with greater selectivity over α-1AR. The characteristic of these molecules are 3,5-dioxo-(2H,4H)-1,2,4-triazine skeleton tethered to an arylpiperazine unit through an alkyl side chain. The most potent 5-HT1AR agonistic properties were found to be associated with the molecules bearing C-4 alkyl group as the linker. Therefore development of 3,5-dioxo-(2H,4H)-1,2,4-triazine bearing arylpiperazine derivatives may provide high affinity selective 5-HT1AR ligands. Herein we describe the synthesis and evaluation of the binding properties of a series of arylpiperazine analogues of 3,5-dioxo-(2H,4H)-1,2,4-triazine.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  5-HT; 5-HT(1A)R; Agonist; Arylpiperazine; α-1AR

Mesh:

Substances:

Year:  2014        PMID: 25182564      PMCID: PMC4294696          DOI: 10.1016/j.bmcl.2014.07.048

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  30 in total

1.  In vivo quantification of human serotonin 1A receptor using 11C-CUMI-101, an agonist PET radiotracer.

Authors:  Matthew S Milak; Christine DeLorenzo; Francesca Zanderigo; Jaya Prabhakaran; J S Dileep Kumar; Vattoly J Majo; J John Mann; Ramin V Parsey
Journal:  J Nucl Med       Date:  2010-12       Impact factor: 10.057

2.  Comparison of high and low affinity serotonin 1A receptors by PET in vivo in nonhuman primates.

Authors:  J S Dileep Kumar; Matthew S Milak; Vattoly J Majo; Jaya Prabhakaran; Pratap Mali; Lyudmila Savenkova; J John Mann; Ramin V Parsey
Journal:  J Pharmacol Sci       Date:  2012-10-16       Impact factor: 3.337

3.  New serotonin 5-HT1A receptor agonists endowed with antinociceptive activity in vivo.

Authors:  Margarita Valhondo; Isabel Marco; Mar Martín-Fontecha; Henar Vázquez-Villa; José A Ramos; Reinhard Berkels; Thomas Lauterbach; Bellinda Benhamú; María L López-Rodríguez
Journal:  J Med Chem       Date:  2013-10-08       Impact factor: 7.446

4.  In vivo serotonin-sensitive binding of [11C]CUMI-101: a serotonin 1A receptor agonist positron emission tomography radiotracer.

Authors:  Matthew S Milak; Alin J Severance; Jaya Prabhakaran; J S Dileep Kumar; Vattoly J Majo; R Todd Ogden; J John Mann; Ramin V Parsey
Journal:  J Cereb Blood Flow Metab       Date:  2010-06-23       Impact factor: 6.200

5.  Autoradiographic evaluation of [3H]CUMI-101, a novel, selective 5-HT1AR ligand in human and baboon brain.

Authors:  J S Dileep Kumar; Ramin V Parsey; Suham A Kassir; Vattoly J Majo; Matthew S Milak; Jaya Prabhakaran; Norman R Simpson; Mark D Underwood; J John Mann; Victoria Arango
Journal:  Brain Res       Date:  2013-02-27       Impact factor: 3.252

Review 6.  Vilazodone: a 5-HT1A receptor agonist/serotonin transporter inhibitor for the treatment of affective disorders.

Authors:  Lee A Dawson; Jeannette M Watson
Journal:  CNS Neurosci Ther       Date:  2009       Impact factor: 5.243

7.  Synthesis and in vivo evaluation of [(18)F]2-(4-(4-(2-(2-fluoroethoxy)phenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5(2H,4H)-dione ([(18)F]FECUMI-101) as an imaging probe for 5-HT1A receptor agonist in nonhuman primates.

Authors:  Vattoly J Majo; Matthew S Milak; Jaya Prabhakaran; Pratap Mali; Lyudmila Savenkova; Norman R Simpson; J John Mann; Ramin V Parsey; J S Dileep Kumar
Journal:  Bioorg Med Chem       Date:  2013-06-12       Impact factor: 3.641

8.  Synthesis and pharmacological evaluation of new 5-(cyclo)alkyl-5-phenyl- and 5-spiroimidazolidine-2,4-dione derivatives. Novel 5-HT1A receptor agonist with potential antidepressant and anxiolytic activity.

Authors:  Anna Czopek; Hanna Byrtus; Marcin Kołaczkowski; Maciej Pawłowski; Małgorzata Dybała; Gabriel Nowak; Ewa Tatarczyńska; Anna Wesołowska; Ewa Chojnacka-Wójcik
Journal:  Eur J Med Chem       Date:  2009-12-06       Impact factor: 6.514

9.  Synthesis of dihydrofuroaporphine derivatives: identification of a potent and selective serotonin 5-HT 1A receptor agonist.

Authors:  Zhili Liu; Hai Zhang; Na Ye; Jing Zhang; QianQian Wu; Peihua Sun; Linyong Li; Xuechu Zhen; Ao Zhang
Journal:  J Med Chem       Date:  2010-02-11       Impact factor: 7.446

Review 10.  5-HT radioligands for human brain imaging with PET and SPECT.

Authors:  Louise M Paterson; Birgitte R Kornum; David J Nutt; Victor W Pike; Gitte M Knudsen
Journal:  Med Res Rev       Date:  2011-06-14       Impact factor: 12.944

View more
  2 in total

1.  Autoradiographic Evaluation of [(18)F]FECUMI-101, a High Affinity 5-HT1AR Ligand in Human Brain.

Authors:  J S Dileep Kumar; Mark D Underwood; Norman R Simpson; Suham A Kassir; Jaya Prabhakaran; Vattoly J Majo; Mihran J Bakalian; Ramin V Parsey; J John Mann; Victoria Arango
Journal:  ACS Med Chem Lett       Date:  2016-03-13       Impact factor: 4.345

2.  Prediction of overall in vitro microsomal stability of drug candidates based on molecular modeling and support vector machines. Case study of novel arylpiperazines derivatives.

Authors:  Szymon Ulenberg; Mariusz Belka; Marek Król; Franciszek Herold; Weronika Hewelt-Belka; Agata Kot-Wasik; Tomasz Bączek
Journal:  PLoS One       Date:  2015-03-31       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.